Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1992 Feb 11;20(3):459–465. doi: 10.1093/nar/20.3.459

Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)hypoxanthine.

Y C Liaw 1, Y G Gao 1, V E Marquez 1, A H Wang 1
PMCID: PMC310408  PMID: 1741280

Abstract

The x-ray crystal structures of two new anti-HIV compounds, 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (2'-F-dd-araA) and 9-(2,3-dideoxy-2-fluoro-beta-D-threo- pentofuranosyl)hypoxanthine (2'-F-dd-aral), have been determined at two temperatures. Both crystals are in the space group P2(1)2(1)2(1), and their structures were solved by direct methods. Least-squares refinement produced final R-factors of 0.027 for the 2'-F-dd-araA structure and of 0.044 for the 2'-F-dd-aral structure, respectively. The latter structure contains a two-fold disordered conformation of the sugar moiety. All three conformers (one for 2'-F-dd-araA and two for 2'-F-dd-aral) adopt an anti chi CN glycosyl torsion angle. The sugar in the 2'-F-dd-araA structure has a C2'-endo pucker conformation, whereas the sugar in the 2'-F-dd-aral structure has a mixture of C2'-endo and C3'-endo pucker conformations. When the sugar adopts the C2'-endo conformation, the torsion angle about the C4'-C5' bond is in a transgauche+ conformation. In contrast, when the sugar adopts the C3'-endo conformation, the torsion angle about the C4'-C5' bond is in a gauche(+)-gauche- conformation. The C2'-F bond distance is 1.406(3) A, similar to that found in other aliphatic C-F bonds. The results suggest that the 2'-fluoro-2',3'-dideoxyarabinosyl nucleosides do not have a strong preference for either C2'-endo or C3'-endo sugar pucker.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnbaum G. I., Lin T. S., Prusoff W. H. Unusual structural features of 2',3'-dideoxycytidine, an inhibitor of the HIV (AIDS) virus. Biochem Biophys Res Commun. 1988 Feb 29;151(1):608–614. doi: 10.1016/0006-291x(88)90637-7. [DOI] [PubMed] [Google Scholar]
  2. Camerman A., Mastropaolo D., Camerman N. Azidothymidine: crystal structure and possible functional role of the azido group. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8239–8242. doi: 10.1073/pnas.84.23.8239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Camerman N., Mastropaolo D., Camerman A. Structure of the anti-human immunodeficiency virus agent 3'-fluoro-3'-deoxythymidine and electronic charge calculations for 3'-deoxythymidines. Proc Natl Acad Sci U S A. 1990 May;87(9):3534–3537. doi: 10.1073/pnas.87.9.3534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coll M., Sherman S. E., Gibson D., Lippard S. J., Wang A. H. Molecular structure of the complex formed between the anticancer drug cisplatin and d(pGpG): C222(1) crystal form. J Biomol Struct Dyn. 1990 Oct;8(2):315–330. doi: 10.1080/07391102.1990.10507808. [DOI] [PubMed] [Google Scholar]
  5. Fridland A., Johnson M. A., Cooney D. A., Ahluwalia G., Marquez V. E., Driscoll J. S., Johns D. G. Metabolism in human leukocytes of anti-HIV dideoxypurine nucleosides. Ann N Y Acad Sci. 1990;616:205–216. doi: 10.1111/j.1749-6632.1990.tb17841.x. [DOI] [PubMed] [Google Scholar]
  6. Hakoshima T., Omori H., Tomita K., Miki H., Ikehara M. The crystal and molecular structure of 2'-deoxy-2'-fluoroinosine monohydrate. Nucleic Acids Res. 1981 Feb 11;9(3):711–729. doi: 10.1093/nar/9.3.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hao Z., Cooney D. A., Farquhar D., Perno C. F., Zhang K., Masood R., Wilson Y., Hartman N. R., Balzarini J., Johns D. G. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate. Mol Pharmacol. 1990 Feb;37(2):157–163. [PubMed] [Google Scholar]
  8. Herdewijn P., Pauwels R., Baba M., Balzarini J., De Clercq E. Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. J Med Chem. 1987 Nov;30(11):2131–2137. doi: 10.1021/jm00394a034. [DOI] [PubMed] [Google Scholar]
  9. Kelley J. A., Litterst C. L., Roth J. S., Vistica D. T., Poplack D. G., Cooney D. A., Nadkarni M., Balis F. M., Broder S., Johns D. G. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos. 1987 Sep-Oct;15(5):595–601. [PubMed] [Google Scholar]
  10. Marquez V. E., Tseng C. K., Kelley J. A., Mitsuya H., Broder S., Roth J. S., Driscoll J. S. 2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). Biochem Pharmacol. 1987 Sep 1;36(17):2719–2722. doi: 10.1016/0006-2952(87)90254-1. [DOI] [PubMed] [Google Scholar]
  11. Marquez V. E., Tseng C. K., Mitsuya H., Aoki S., Kelley J. A., Ford H., Jr, Roth J. S., Broder S., Johns D. G., Driscoll J. S. Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. J Med Chem. 1990 Mar;33(3):978–985. doi: 10.1021/jm00165a015. [DOI] [PubMed] [Google Scholar]
  12. Silverton J. V., Quinn F. R., Haugwitz R. D., Torado L. J. Structures of two dideoxynucleosides: 2',3'-dideoxyadenosine and 2',3'-dideoxycytidine. Acta Crystallogr C. 1988 Feb 15;44(Pt 2):321–324. doi: 10.1107/s0108270187009910. [DOI] [PubMed] [Google Scholar]
  13. Van Roey P., Salerno J. M., Chu C. K., Schinazi R. F. Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus. Proc Natl Acad Sci U S A. 1989 Jun;86(11):3929–3933. doi: 10.1073/pnas.86.11.3929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Waqar M. A., Evans M. J., Manly K. F., Hughes R. G., Huberman J. A. Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses. J Cell Physiol. 1984 Nov;121(2):402–408. doi: 10.1002/jcp.1041210218. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES